Leerink Partnrs Cuts Earnings Estimates for DENTSPLY SIRONA

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) – Stock analysts at Leerink Partnrs dropped their FY2027 EPS estimates for DENTSPLY SIRONA in a note issued to investors on Tuesday, October 14th. Leerink Partnrs analyst M. Cherny now forecasts that the medical instruments supplier will earn $2.31 per share for the year, down from their prior estimate of $2.34. The consensus estimate for DENTSPLY SIRONA’s current full-year earnings is $1.84 per share. Leerink Partnrs also issued estimates for DENTSPLY SIRONA’s FY2028 earnings at $2.63 EPS.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 EPS for the quarter, beating analysts’ consensus estimates of $0.50 by $0.02. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. The firm had revenue of $936.00 million for the quarter, compared to analysts’ expectations of $929.67 million. During the same quarter in the prior year, the company posted $0.49 earnings per share. The business’s revenue for the quarter was down 4.9% on a year-over-year basis. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS.

Other research analysts also recently issued reports about the stock. Wall Street Zen downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Saturday. Needham & Company LLC reissued a “hold” rating on shares of DENTSPLY SIRONA in a research note on Friday, September 26th. Stifel Nicolaus reduced their price objective on shares of DENTSPLY SIRONA from $19.00 to $17.00 and set a “hold” rating for the company in a research note on Friday, August 8th. Barrington Research reduced their price objective on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set an “outperform” rating for the company in a research note on Friday, August 8th. Finally, Evercore ISI cut their target price on shares of DENTSPLY SIRONA from $17.00 to $13.00 and set an “in-line” rating for the company in a research note on Wednesday, October 8th. Two analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $18.00.

DENTSPLY SIRONA Stock Down 0.9%

Shares of DENTSPLY SIRONA stock opened at $12.51 on Thursday. The company has a market cap of $2.50 billion, a price-to-earnings ratio of -2.64, a price-to-earnings-growth ratio of 0.79 and a beta of 0.96. The company’s 50 day moving average is $13.38 and its 200 day moving average is $14.52. DENTSPLY SIRONA has a twelve month low of $11.69 and a twelve month high of $24.86. The company has a quick ratio of 1.11, a current ratio of 1.69 and a debt-to-equity ratio of 1.13.

DENTSPLY SIRONA Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, October 10th. Investors of record on Friday, September 26th were paid a dividend of $0.16 per share. The ex-dividend date of this dividend was Friday, September 26th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 5.1%. DENTSPLY SIRONA’s payout ratio is currently -13.50%.

Institutional Investors Weigh In On DENTSPLY SIRONA

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Mirae Asset Global Investments Co. Ltd. bought a new stake in DENTSPLY SIRONA during the 1st quarter valued at about $25,000. Brooklyn Investment Group bought a new stake in DENTSPLY SIRONA during the 1st quarter valued at about $26,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in shares of DENTSPLY SIRONA in the 1st quarter valued at about $26,000. Trust Co. of Toledo NA OH bought a new stake in shares of DENTSPLY SIRONA in the 2nd quarter valued at about $27,000. Finally, Parkside Financial Bank & Trust raised its holdings in shares of DENTSPLY SIRONA by 620.6% in the 2nd quarter. Parkside Financial Bank & Trust now owns 1,715 shares of the medical instruments supplier’s stock valued at $27,000 after purchasing an additional 1,477 shares in the last quarter. Institutional investors own 95.70% of the company’s stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.